Physician profile
Aneta Strus
NPI 1760892467
$7,782.96
in general payments reported to CMS, 2019-2025
23 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,522 · 2020: $233 · 2021: $199 · 2022: $727 · 2023: $577 · 2024: $239 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,250.50 | 2019 | |
| Stryker Corporation | $1,205.87 | 2019-2025 | Augment Injectable, Valor, 7 X 23mm Citrelock Implant |
| Novus Surgical Consultants | $208.02 | 2023-2025 | |
| Nevro Corp. | $171.95 | 2019-2022 | |
| Novus Surgical Solutions LLC | $143.99 | 2022 | |
| Abbott Laboratories | $142.24 | 2023 | Proclaim |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Merck Sharp & Dohme LLC | $93.61 | 2019 | |
| Organogenesis INC. | $73.36 | 2020-2024 | Affinity, Puraply |
| Smith+Nephew, INC. | $71.65 | 2023-2024 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Zimmer Biomet Holdings, INC. | $45.03 | 2019 | |
| Novastep INC. | $34.10 | 2021 | |
| Djo, LLC | $30.28 | 2020-2021 | |
| Grt US Holding, INC. | $29.17 | 2020-2022 | |
| Trice Medical, INC. | $26.13 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $25.37 | 2019 | |
| Kerecis Limited | $19.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $19.10 | 2023 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Alfasigma USA, INC. | $15.90 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $13.88 | 2025 | |
| Paragon 28, INC. | $13.21 | 2019 | |
| Integra Lifesciences Corporation | $12.53 | 2019 | |
| Zyla Life Sciences, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aneta Strus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.